| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |